CHICAGO, Sept. 26, 2023 /PRNewswire/ -- HOPPR, an AI company creating a platform for physicians, technicians, and support staff to interact dynamically with medical imaging studies, today announces the expansion of its executive team with the appointment of leading experts in radiology, business transformation, and health tech commercialization.

芝加哥，2023年9月26日/PRNewswire/-人工智能公司HOPPR为医生，技术人员和支持人员创建一个与医学成像研究动态互动的平台，今天宣布扩大其执行团队，任命领先的放射学，商业转型和健康技术商业化专家。

Dr. Oliver Chen joins HOPPR as Chief Medical Officer, Robert Bakos as Chief Technology Officer, Ted Schwab as Chief Development Officer, and Jory Tremblay as Chief Commercial Officer. Under their leadership, HOPPR will supercharge AI application development in the medical imaging space..

Oliver Chen博士加入HOPPR担任首席医疗官，Robert Bakos担任首席技术官，Ted Schwab担任首席开发官，Jory Tremblay担任首席商业官。在他们的领导下，HOPPR将推动医学成像领域的人工智能应用开发。。

Continue Reading

继续阅读

HOPPR co-founder Dr. Oliver Chen will serve as Chief Medical Officer. A clinical neuroradiologist and AI expert, Dr. Chen previously worked at Microsoft, where he launched initiatives for machine learning, medical imaging, and human image recognition.  The algorithms he helped create became the foundation for Xbox Kinect.

HOPPR联合创始人Oliver Chen博士将担任首席医疗官。临床神经放射学家和人工智能专家陈博士以前曾在微软工作，在那里他发起了机器学习，医学成像和人类图像识别的计划。他帮助创建的算法成为Xbox Kinect的基础。

After finishing his undergraduate work at MIT, Dr. Chen completed medical school at Harvard, a radiology residency at UCLA, a neuroradiology fellowship at UCSF, and served on the faculty of NYU Medical School. Dr. Chen is a serial entrepreneur who founded and sold ilumihealth..

在麻省理工学院完成本科工作后，陈博士完成了哈佛大学医学院，加州大学洛杉矶分校放射学住院医师，加州大学旧金山分校神经放射学奖学金，并在纽约大学医学院任职。陈博士是一位创立和销售ilumihealth的连续企业家。。

HOPPR co-founder and Chief Technology Officer Robert Bakos is a seasoned leader and software development visionary, specializing in the domains of digital health and medical imaging. Before embarking on his journey with HOPPR, Robert held the role of Chief Technology Officer at Higi, Inc., a major player in consumer health engagement.

HOPPR联合创始人兼首席技术官Robert Bakos是一位经验丰富的领导者和软件开发愿景，专门从事数字健康和医学成像领域。在开始与HOPPR的旅程之前，罗伯特担任Higi，Inc。的首席技术官，Higi，Inc。是消费者健康参与的主要参与者。

During his tenure there, he played a pivotal role in establishing and nurturing the engineering team, spearheading the formulation of the technology strategy, architecting the robust technology infrastructure, and orchestrating the development of an innovative software suite. His leadership at Higi was instrumental in propelling the company's success in the consumer health sector.  Prior to joining Higi, Mr.

在他任职期间，他在建立和培养工程团队，率先制定技术战略，构建强大的技术基础设施以及协调创新软件套件的开发方面发挥了关键作用。他在Higi的领导层有助于推动该公司在消费者健康领域的成功。在加入Higi之前，先生。

Bakos managed a development team within Merge Healthcare (IBM Watson Imaging), focusing on RIS/PACS integrations and innovative solutions to optimize patient experience..

Bakos管理Merge Healthcare（IBM Watson Imaging）内的开发团队，专注于RIS/PACS集成和创新解决方案，以优化患者体验。。

Ted Schwab joins HOPPR as Chief Development Officer, bringing more than 35 years of experience in healthcare innovation and strategy, health system operations, and health tech startups. Mr. Schwab was the second Chief Innovation Officer in the entire healthcare industry, a role in which he launched over 200 initiatives and was a founding member of the Innovation Learning Network.

Ted Schwab加入HOPPR担任首席开发官，在医疗保健创新和战略，卫生系统运营和卫生技术创业公司拥有超过35年的经验。Schwab先生是整个医疗行业的第二位首席创新官，他发起了200多项举措，并且是创新学习网络的创始成员。

He has spent the last six years investing in, building, and driving the commercialization of health tech start-ups through Schwab Tremblay Solutions, a boutique interim healthcare management company for healthcare startups. In this capacity, he has successfully managed the launch of companies, raised money, and developed boards and clinical partnerships..

他在过去六年中通过Schwab Tremblay Solutions投资，建设和推动健康技术初创企业的商业化，Schwab Tremblay Solutions是一家为医疗创业公司提供的高品质临时医疗管理公司。以此能力，他成功地管理了公司的启动，筹集资金以及开发的董事会和临床合作伙伴关系。。

Jory Tremblay joins HOPPR as Chief Commercial Officer. He is a seasoned entrepreneur and technology strategist with 30 years of experience entering and scaling in new markets. Mr. Tremblay's extensive career spans global sales and marketing leadership, M&A, and advisory roles. With 18+ years in AI, he's led product development, technology sales, and operations, including the launch of six AI-based products.

Jory Tremblay加入HOPPR担任首席商业官。他是一位经验丰富的企业家和技术战略家，拥有进入和拓展新市场30年的经验。Tremblay先生的广泛职业生涯涵盖全球销售和营销领导力，M＆A和咨询职位。在人工智能领域拥有18多年的历史，他领导着产品开发，技术销售和运营，包括推出六款基于人工智能的产品。

A trusted advisor and investor, Mr. Tremblay has led over $125 million in investments. He's a pioneer in building one of the first ACOs in the United States, and his diverse experience includes a senior management role at the AI company Fetch Technologies, Inc., managing EspressoSat, and co-founding Provence Capital and Schwab Tremblay Solutions, where he has successfully managed the launch of companies, raised money, and developed boards and clinical partnerships..

Tremblay先生是一位值得信赖的顾问和投资者，他已经投资了超过1.25亿美元。他是在美国建造首批ACO之一的先驱，他的丰富经验包括AI公司Fetch Technologies，Inc。的高级管理人员，管理EspressoSat，并共同创立普罗旺斯首都和Schwab Tremblay Solutions，他已成功管理公司的推出，筹集资金，并开发董事会和临床合作伙伴关系。。

HOPPR appoints leading experts in AI, radiology, and health tech commercialization to leadership team

HOPPR任命人工智能、放射学和健康技术商业化方面的领先专家到领导团队

Tweet this

推特这个

HOPPR CEO Dr. Khan M. Siddiqui expressed his excitement about the expansion of HOPPR's leadership team, commenting, 'With these appointments, HOPPR is ideally positioned to unlock the full potential of medical images. Oliver, Robert, Ted, and Jory bring the combination of clinical excellence, technological expertise, and entrepreneurial prowess we need to create a future where neuroradiologists can not just interpret but truly interact with medical imagery.'.

HOPPR首席执行官Khan M.Siddiqui博士对HOPPR领导团队的扩张表示兴奋，并评论说：“通过这些任命，HOPPR处于充分发挥医学图像潜力的理想位置。Oliver，Robert，Ted和Jory将临床卓越，技术专长和创业实力相结合，我们需要创造一个神经放射学家不仅可以解释而且可以与医学意象真正互动的未来。

About HOPPR: HOPPR is changing medical imaging forever. We are enabling physicians, technicians, and clinical support staff to have conversations with medical imaging studies, transforming medical imaging interactions from static to dynamic. We have created both medical and administrative use cases that we will unveil with commercial partners at RSNA in November 2023.For media inquiries, please contact Kalia Ataliotou at [email protected]. SOURCE HOPPR.

关于HOPPR:HOPPR永远在改变医学成像。我们使医生，技术人员和临床支持人员能够与医学成像研究进行对话，将医学成像交互从静态转变为动态。我们已经创建了医疗和行政用例，我们将于2023年11月在RSNA与商业合作伙伴一起推出。有关媒体查询，请通过[电子邮件保护]与Kalia Ataliotou联系。来源HOPPR。